Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

NCT01791088 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG: sirolimus
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

University of Chicago

Collaborators

[object Object]